前收市價 | 55.07 |
開市 | 56.75 |
買盤 | 55.86 x 500 |
賣出價 | 55.94 x 500 |
今日波幅 | 55.57 - 58.45 |
52 週波幅 | 37.55 - 91.10 |
成交量 | |
平均成交量 | 1,710,538 |
市值 | 4.744B |
Beta 值 (5 年,每月) | 1.74 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.94 |
業績公佈日 | 2024年2月21日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 85.88 |
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $55.89, indicating a +1.49% shift from the previous trading day.
It pays to develop novel medicines for life-threatening illnesses.
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.